However, even mild to moderate weight reduction in the order of 3–4%, as found in our study, was associated with measurable beneficial cardiometabolic effects, including significant reductions in anthropometric indices (BMI and waist, hip and neck circumference), glucose, total cholesterol, LDL-C, ALT (a biomarker of fatty liver disease [22]), triglycerides, aminotransferases, and uric acid. Here, GPT is linked to fatty liver disease.